These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 19231125)

  • 1. Does tumor type affect local control by radiofrequency ablation in the lungs?
    Hiraki T; Gobara H; Mimura H; Sano Y; Tsuda T; Iguchi T; Fujiwara H; Kishi R; Matsui Y; Kanazawa S
    Eur J Radiol; 2010 Apr; 74(1):136-41. PubMed ID: 19231125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control?
    Hiraki T; Mimura H; Gobara H; Sano Y; Fujiwara H; Date H; Kanazawa S
    J Vasc Interv Radiol; 2008 May; 19(5):706-11. PubMed ID: 18440459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors.
    Hiraki T; Sakurai J; Tsuda T; Gobara H; Sano Y; Mukai T; Hase S; Iguchi T; Fujiwara H; Date H; Kanazawa S
    Cancer; 2006 Dec; 107(12):2873-80. PubMed ID: 17096433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience.
    Clark TW; Malkowicz B; Stavropoulos SW; Sanchez R; Soulen MC; Itkin M; Patel A; Mondschein JI; Wein AJ
    J Vasc Interv Radiol; 2006 Mar; 17(3):513-9. PubMed ID: 16567676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
    Komorizono Y; Oketani M; Sako K; Yamasaki N; Shibatou T; Maeda M; Kohara K; Shigenobu S; Ishibashi K; Arima T
    Cancer; 2003 Mar; 97(5):1253-62. PubMed ID: 12599233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
    J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.
    Chow DH; Sinn LH; Ng KK; Lam CM; Yuen J; Fan ST; Poon RT
    J Surg Oncol; 2006 Dec; 94(7):565-71. PubMed ID: 17048238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.
    Fernando HC; De Hoyos A; Landreneau RJ; Gilbert S; Gooding WE; Buenaventura PO; Christie NA; Belani C; Luketich JD
    J Thorac Cardiovasc Surg; 2005 Mar; 129(3):639-44. PubMed ID: 15746749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates.
    Hiraki T; Gobara H; Iishi T; Sano Y; Iguchi T; Fujiwara H; Tajiri N; Sakurai J; Date H; Mimura H; Kanazawa S
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1306-12. PubMed ID: 17976467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system.
    Glaiberman CB; Pilgram TK; Brown DB
    J Vasc Interv Radiol; 2005 Oct; 16(10):1341-8. PubMed ID: 16221905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
    Mahnken AH; Bruners P; Tacke JA; Günther RW
    Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
    Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
    Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of a 'popping' sound during percutaneous radiofrequency ablation for hepatocellular carcinoma.
    Fernandes ML; Lin CC; Lin CJ; Chen WT; Lin SM
    J Vasc Interv Radiol; 2010 Feb; 21(2):237-44. PubMed ID: 20031448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative radiofrequency ablation for hepatocellular carcinoma: long-term results in a large series.
    Kim YS; Rhim H; Lim HK; Choi D; Lee WJ; Jeon TY; Joh JW; Kim SJ
    Ann Surg Oncol; 2008 Jul; 15(7):1862-70. PubMed ID: 18463926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
    Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
    Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection.
    Rouvière O; Badet L; Murat FJ; Maréchal JM; Colombel M; Martin X; Lyonnet D; Gelet A
    Cardiovasc Intervent Radiol; 2008; 31(3):595-603. PubMed ID: 18247086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.